Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Capricor Therapeutics (CAPR) Non-cash Items (2019 - 2024)

Capricor Therapeutics (CAPR) has 7 years of Non-cash Items data on record, last reported at $101.8 million in Q4 2024.

  • For Q4 2024, Non-cash Items rose 714.73% year-over-year to $101.8 million; the TTM value through Dec 2024 reached $101.8 million, up 714.73%, while the annual FY2024 figure was $101.8 million, 714.73% up from the prior year.
  • Non-cash Items reached $101.8 million in Q4 2024 per CAPR's latest filing, up from $16.6 million in the prior quarter.
  • Across five years, Non-cash Items topped out at $101.8 million in Q4 2024 and bottomed at $171000.0 in Q1 2020.
  • Average Non-cash Items over 5 years is $14.5 million, with a median of $12.0 million recorded in 2022.
  • The widest YoY moves for Non-cash Items: up 4870.76% in 2021, down 26.72% in 2021.
  • A 5-year view of Non-cash Items shows it stood at $4.2 million in 2020, then dropped by 26.72% to $3.1 million in 2021, then skyrocketed by 85.97% to $5.8 million in 2022, then soared by 116.38% to $12.5 million in 2023, then soared by 714.73% to $101.8 million in 2024.
  • Per Business Quant database, its latest 3 readings for Non-cash Items were $101.8 million in Q4 2024, $16.6 million in Q3 2024, and $19.2 million in Q2 2024.